Platinum-resistant Epithelial Ovarian Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB01101 | Capecitabine | A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer. |
DB12489 | Mirvetuximab soravtansine | A folate receptor alpha-directed antibody and microtubule inhibitor conjugate used to treat folate receptor alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00997 | Doxorubicin | 1 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 | Terminated | 1 |
DB01611 | Hydroxychloroquine | 1 / 2 | Completed | 1 |
DB01167 | Itraconazole | 1 / 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 2 | Terminated | 1 |
DB17339 | Maveropepimut-S | 2 | Terminated | 1 |